Mini GPS in a needle could help doctors hit hidden tumors
NCT ID NCT00102544
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 6 times
Summary
This study tests a special needle with a tiny tracking device inside, like a mini GPS, to help doctors find tumors that are hard to see on CT scans. About 3,900 adults with certain cancers or growths will have their biopsy or ablation procedure done using this smart needle. The goal is to see if the system can accurately guide the needle to the right spot, potentially making these procedures more precise.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Electromagnetic tracking device (GPS-like needle guidance system)
- What this could lead to
- If successful, this technology could make biopsies and tumor ablations more accurate and safer by helping doctors precisely target hard-to-see lesions.
- What could go wrong
- This is an early feasibility study focused on accuracy, not treatment outcomes. The device may not improve success rates or reduce complications in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?